Literature DB >> 3817333

Crohn's disease in Jewish people--an epidemiological study in south-east Wales.

J F Mayberry, D Judd, H Smart, J Rhodes, B Calcraft, J S Morris.   

Abstract

The prevalence of Crohn's disease in the Jewish population of south-east Wales was established by a postal survey, review of case notes and a survey of Jewish congregations in the three synagogues of the area. The prevalence of Crohn's disease had been established in various earlier studies at 52/10(5). Seven Jewish patients were identified amongst a population of between 1,750 and 2,500. The prevalence ranged from 280 to 400/10(5) (95% confidence interval 120-862/10(5]. There was no significant difference in prevalence between orthodox and reformed Jews. Jewish people are at a relative risk of developing Crohn's disease of 5.4-7.7 (95% confidence interval 2.3-17.2, p less than 0.001), but the role of diet is yet to be established.

Entities:  

Mesh：

Year:  1986        PMID： 3817333     DOI： 10.1159/000199374

Source DB:  PubMed          Journal:  Digestion        ISSN： 0012-2823            Impact factor:   3.216


  8 in total

Review 1.  Recent epidemiology of ulcerative colitis and Crohn's disease.

Authors:  J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues.

Authors:  C S Probert; V Jayanthi; D S Rampton; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

3.  [Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases].

Authors:  H C Rath; T Andus; I Caesar; J Schölmerich
Journal:  Med Klin (Munich)       Date:  1998-07-15

4.  A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.

Authors:  Ling-Shiang Chuang; Nicole Villaverde; Ken Y Hui; Arthur Mortha; Adeeb Rahman; Adam P Levine; Talin Haritunians; Sok Meng Evelyn Ng; Wei Zhang; Nai-Yun Hsu; Jody-Ann Facey; Tramy Luong; Heriberto Fernandez-Hernandez; Dalin Li; Manuel Rivas; Elena R Schiff; Alexander Gusev; L Phillip Schumm; Beatrice M Bowen; Yashoda Sharma; Kaida Ning; Romain Remark; Sacha Gnjatic; Peter Legnani; James George; Bruce E Sands; Joanne M Stempak; Lisa W Datta; Seth Lipka; Seymour Katz; Adam S Cheifetz; Nir Barzilai; Nikolas Pontikos; Clara Abraham; Marla J Dubinsky; Stephan Targan; Kent Taylor; Jerome I Rotter; Ellen J Scherl; Robert J Desnick; Maria T Abreu; Hongyu Zhao; Gil Atzmon; Itsik Pe'er; Subra Kugathasan; Hakon Hakonarson; Jacob L McCauley; Todd Lencz; Ariel Darvasi; Vincent Plagnol; Mark S Silverberg; Aleixo M Muise; Steven R Brant; Mark J Daly; Anthony W Segal; Richard H Duerr; Miriam Merad; Dermot P B McGovern; Inga Peter; Judy H Cho
Journal:  Gastroenterology       Date:  2016-07-01       Impact factor: 22.682

5.  A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

Authors:  Elena R Schiff; Matthew Frampton; Francesca Semplici; Stuart L Bloom; Sara A McCartney; Roser Vega; Laurence B Lovat; Eleanor Wood; Ailsa L Hart; Daniel Crespi; Mark A Furman; Steven Mann; Charles D Murray; Anthony W Segal; Adam P Levine
Journal:  Dig Dis Sci       Date:  2018-09-03       Impact factor: 3.199

6.  Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3.

Authors:  W Zhang; K Y Hui; A Gusev; N Warner; S M E Ng; J Ferguson; M Choi; A Burberry; C Abraham; L Mayer; R J Desnick; C J Cardinale; H Hakonarson; M Waterman; Y Chowers; A Karban; S R Brant; M S Silverberg; P K Gregersen; S Katz; R P Lifton; H Zhao; G Nuñez; I Pe'er; I Peter; J H Cho
Journal:  Genes Immun       Date:  2013-04-25       Impact factor: 2.676

Review 7.  Inflammatory bowel disease: an expanding global health problem.

Authors:  Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2013-08-14

8.  Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Authors:  E R Schiff; M Frampton; N Ben-Yosef; B E Avila; F Semplici; N Pontikos; S L Bloom; S A McCartney; R Vega; L B Lovat; E Wood; A Hart; E Israeli; D Crespi; M A Furman; S Mann; C D Murray; A W Segal; A P Levine
Journal:  Hum Genet       Date:  2018-08-22       Impact factor: 4.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.